相似文献
1
Update on Management of Type 2 Diabetes for Cardiologists.心脏病专家对2型糖尿病管理的最新进展
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):273-280. doi: 10.14797/mdcj-14-4-273.
2
Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure.2型糖尿病合并心力衰竭的分期管理
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):257-265. doi: 10.14797/mdcj-14-4-257.
3
The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.2型糖尿病治疗模式的转变——心脏病专家的观点
Clin Cardiol. 2017 Nov;40(11):970-973. doi: 10.1002/clc.22781. Epub 2017 Aug 25.
4
Diabetes: Time for reconciliation between cardiologists and diabetologists.糖尿病：心脏病专家与糖尿病专家和解的时候了。
Nat Rev Cardiol. 2016 Sep;13(9):509-10. doi: 10.1038/nrcardio.2016.113. Epub 2016 Jul 14.
5
How to prevent diabetes-triggered heart disease.如何预防糖尿病引发的心脏病。
Eur J Prev Cardiol. 2018 Nov;25(16):1789. doi: 10.1177/2047487318777439. Epub 2018 May 17.
6
Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials.胰高血糖素样肽-1 受体激动剂在心血管疾病中的临床应用：来自最近的心血管临床结局试验的经验。
Cardiovasc Diabetol. 2018 Jun 12;17(1):85. doi: 10.1186/s12933-018-0731-y.
7
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).钠-葡萄糖共转运蛋白 2（SGLT2）抑制剂降低 2 型糖尿病（T2DM）患者心血管风险的潜力。
J Diabetes Complications. 2013 May-Jun;27(3):280-6. doi: 10.1016/j.jdiacomp.2012.12.004. Epub 2013 Feb 1.
8
The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.低血糖在糖尿病心血管结局中的作用。
Can J Diabetes. 2015 Dec;39 Suppl 5:S155-9. doi: 10.1016/j.jcjd.2015.09.009.
9
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes.钠-葡萄糖共转运蛋白 2（SGLT-2）抑制剂与 2 型糖尿病的治疗。
Annu Rev Med. 2019 Jan 27;70:323-334. doi: 10.1146/annurev-med-042017-094221. Epub 2018 Sep 26.
10
Safety of antidiabetes medications: An update.抗糖尿病药物的安全性：更新。
Clin Pharmacol Ther. 2015 Aug;98(2):185-95. doi: 10.1002/cpt.125. Epub 2015 May 2.
引用本文的文献
1
Inhibiting Glucose Metabolism By miR-34a and miR-125b Protects Against Hyperglycemia-Induced Cardiomyocyte Cell Death.通过miR-34a和miR-125b抑制葡萄糖代谢可预防高血糖诱导的心肌细胞死亡。
Arq Bras Cardiol. 2021 Mar;116(3):415-422. doi: 10.36660/abc.20190529.
2
Predicting complications of diabetes mellitus using advanced machine learning algorithms.使用先进的机器学习算法预测糖尿病并发症。
J Am Med Inform Assoc. 2020 Jul 1;27(9):1343-1351. doi: 10.1093/jamia/ocaa120.
本文引用的文献
1
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.美国临床内分泌医师协会和美国内分泌学会关于2型糖尿病综合管理算法的共识声明 - 2018执行摘要
Endocr Pract. 2018 Jan;24(1):91-120. doi: 10.4158/CS-2017-0153. Epub 2018 Jan 17.
2
9. Cardiovascular Disease and Risk Management: .9. 心血管疾病与风险管理： 。
Diabetes Care. 2018 Jan;41(Suppl 1):S86-S104. doi: 10.2337/dc18-S009.
3
8. Pharmacologic Approaches to Glycemic Treatment: .8. 血糖治疗的药物治疗方法： 。
Diabetes Care. 2018 Jan;41(Suppl 1):S73-S85. doi: 10.2337/dc18-S008.
4
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断： 。
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27. doi: 10.2337/dc18-S002.
5
Updates on cardiovascular outcome trials in diabetes.糖尿病心血管结局试验的最新进展。
Cardiovasc Diabetol. 2017 Oct 11;16(1):128. doi: 10.1186/s12933-017-0610-y.
6
The mechanisms of action of metformin.二甲双胍的作用机制。
Diabetologia. 2017 Sep;60(9):1577-1585. doi: 10.1007/s00125-017-4342-z. Epub 2017 Aug 3.
7
Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials.普兰林肽治疗2型糖尿病的心血管安全性评估：五项临床试验汇总分析结果
Clin Diabetes Endocrinol. 2016 May 11;2:12. doi: 10.1186/s40842-016-0030-z. eCollection 2016.
8
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.德谷胰岛素与甘精胰岛素治疗2型糖尿病的疗效和安全性比较
N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.
9
Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies.磺酰脲类药物与心血管事件和死亡风险：观察性研究的方法学荟萃回归分析。
Diabetes Care. 2017 May;40(5):706-714. doi: 10.2337/dc16-1943.
10
The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials.磺脲类药物使用与全因死亡率和心血管死亡率之间的关联：一项对随机临床试验进行序贯分析的荟萃分析
PLoS Med. 2016 Apr 12;13(4):e1001992. doi: 10.1371/journal.pmed.1001992. eCollection 2016 Apr.
Zotero 插件